Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9002941 | 1.00 | CCKBR (1.00) | CCKBRTP53CYP1A2CYP3A4MAPT | |
| SCHEMBL9203429 | 0.80 | CCKBR (0.80) | CCKBRTP53CYP1A2CYP3A4MAPT | |
| SCHEMBL9209152 | 0.77 | CCKBR (0.76) | CCKBR | |
| SCHEMBL16620509 | 0.72 | HIF1A (0.60) | CCKBRTP53CYP1A2CYP3A4MAPT | |
| SCHEMBL8502010 | 0.71 | SMN1; SMN2 (0.56) | CCKBR | |
| SCHEMBL8503645 | 0.71 | SMN1; SMN2 (0.56) | CCKBR | |
| SCHEMBL6308294 | 0.68 | CCKBR (0.63) | CCKBR | |
| SCHEMBL9209580 | 0.68 | CCKBR (0.60) | CCKBRTP53CYP1A2CYP3A4MAPT | |
| SCHEMBL9203141 | 0.67 | NPC1 (0.64) | CCKBRMAPT | |
| SCHEMBL31525981 | 0.66 | MAPT (0.49) | CCKBRTP53CYP1A2CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250019769-A1 | REPURPOSING DRUGS FOR NON-SMALL CELL LUNG CANCER | West Virginia University Board of Governors on behalf of West Virginia University | 2025-01-16 | — | — | US | disclosed |
| US-20220291237-A1 | Gene Expression Inflammatory Age and Its Uses | Edifice Health, Inc. (US) | 2022-09-15 | — | — | US | disclosed |